These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 31407220)
1. Expressions of Carbohydrate Response Element Binding Protein and Glucose Transporters in Liver Cancer and Clinical Significance. Lei Y; Hu Q; Gu J Pathol Oncol Res; 2020 Apr; 26(2):1331-1340. PubMed ID: 31407220 [TBL] [Abstract][Full Text] [Related]
2. Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progression. Airley RE; McHugh P; Evans AR; Harris B; Winchester L; Buffa FM; Al-Tameemi W; Leek R; Harris AL Br J Cancer; 2014 Feb; 110(3):715-23. PubMed ID: 24366300 [TBL] [Abstract][Full Text] [Related]
3. Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation. Lei Y; Zhou S; Hu Q; Chen X; Gu J Sci Rep; 2020 Mar; 10(1):4233. PubMed ID: 32144313 [TBL] [Abstract][Full Text] [Related]
4. Hormonally Induced Hepatocellular Carcinoma in Diabetic Wild Type and Carbohydrate Responsive Element Binding Protein Knockout Mice. Nuernberger V; Mortoga S; Metzendorf C; Burkert C; Ehricke K; Knuth E; Zimmer J; Singer S; Nath N; Karim M; Yasser M; Calvisi DF; Dombrowski F; Ribback S Cells; 2021 Oct; 10(10):. PubMed ID: 34685767 [TBL] [Abstract][Full Text] [Related]
5. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Amann T; Maegdefrau U; Hartmann A; Agaimy A; Marienhagen J; Weiss TS; Stoeltzing O; Warnecke C; Schölmerich J; Oefner PJ; Kreutz M; Bosserhoff AK; Hellerbrand C Am J Pathol; 2009 Apr; 174(4):1544-52. PubMed ID: 19286567 [TBL] [Abstract][Full Text] [Related]
6. Flightless I homolog negatively regulates ChREBP activity in cancer cells. Wu L; Chen H; Zhu Y; Meng J; Li Y; Li M; Yang D; Zhang P; Feng M; Tong X Int J Biochem Cell Biol; 2013 Nov; 45(11):2688-97. PubMed ID: 24055811 [TBL] [Abstract][Full Text] [Related]
7. Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes. Stoeckman AK; Ma L; Towle HC J Biol Chem; 2004 Apr; 279(15):15662-9. PubMed ID: 14742444 [TBL] [Abstract][Full Text] [Related]
8. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma. Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438 [TBL] [Abstract][Full Text] [Related]
9. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression. Shang R; Pu M; Li Y; Wang D Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073 [TBL] [Abstract][Full Text] [Related]
10. Direct role of ChREBP.Mlx in regulating hepatic glucose-responsive genes. Ma L; Tsatsos NG; Towle HC J Biol Chem; 2005 Mar; 280(12):12019-27. PubMed ID: 15664996 [TBL] [Abstract][Full Text] [Related]
11. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice. Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275 [TBL] [Abstract][Full Text] [Related]
12. Sweet dreams could be made of this: carbohydrate-responsive element-binding protein (ChREBP) as a target for hepatocellular carcinoma therapy. Fernández-Barrena MG; Avila MA Mol Oncol; 2024 Sep; 18(9):2107-2110. PubMed ID: 38837736 [TBL] [Abstract][Full Text] [Related]
13. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. Dentin R; Pégorier JP; Benhamed F; Foufelle F; Ferré P; Fauveau V; Magnuson MA; Girard J; Postic C J Biol Chem; 2004 May; 279(19):20314-26. PubMed ID: 14985368 [TBL] [Abstract][Full Text] [Related]
14. Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma. Ribback S; Che L; Pilo MG; Cigliano A; Latte G; Pes GM; Porcu A; Pascale RM; Li L; Qiao Y; Dombrowski F; Chen X; Calvisi DF Cell Cycle; 2018; 17(12):1496-1512. PubMed ID: 29965794 [TBL] [Abstract][Full Text] [Related]
15. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Ishii S; Iizuka K; Miller BC; Uyeda K Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15597-602. PubMed ID: 15496471 [TBL] [Abstract][Full Text] [Related]
16. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters. Kasai D; Adachi T; Deng L; Nagano-Fujii M; Sada K; Ikeda M; Kato N; Ide YH; Shoji I; Hotta H J Hepatol; 2009 May; 50(5):883-94. PubMed ID: 19303158 [TBL] [Abstract][Full Text] [Related]
17. The glucose-sensing transcription factor ChREBP is targeted by proline hydroxylation. Heidenreich S; Weber P; Stephanowitz H; Petricek KM; Schütte T; Oster M; Salo AM; Knauer M; Goehring I; Yang N; Witte N; Schumann A; Sommerfeld M; Muenzner M; Myllyharju J; Krause E; Schupp M J Biol Chem; 2020 Dec; 295(50):17158-17168. PubMed ID: 33023907 [TBL] [Abstract][Full Text] [Related]
18. The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism. Iizuka K Nutrients; 2017 Feb; 9(2):. PubMed ID: 28241431 [TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products promote ChREBP expression and cell proliferation in liver cancer cells by increasing reactive oxygen species. Chen H; Li Y; Zhu Y; Wu L; Meng J; Lin N; Yang D; Li M; Ding W; Tong X; Su Q Medicine (Baltimore); 2017 Aug; 96(33):e7456. PubMed ID: 28816938 [TBL] [Abstract][Full Text] [Related]
20. ChREBP downregulates SNAT2 amino acid transporter expression through interactions with SMRT in response to a high-carbohydrate diet. Velázquez-Villegas L; Noriega LG; López-Barradas AM; Tobon-Cornejo S; Méndez-García AL; Tovar AR; Torres N; Ortiz-Ortega VM Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E102-E112. PubMed ID: 33225719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]